By August they had the first conclusive results: when they gave the material extracted from the islets of Langerhans (called "insulin," from the Latin for "island") to diabetic dogs, their ...

The drug, known as LOY-002, aims to reduce aging in canines by fending off age-related metabolic changes, such as insulin resistance, which can mitigate and reverse the effects of aging in dogs.